GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nhlh1 | rn6_v1_chr13_-_90443157_90443157 | 0.53 | 1.5e-24 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_176666282 Show fit | 46.19 |
ENSRNOT00000016947
|
eukaryotic translation elongation factor 1 alpha 2 |
|
chr8_+_111600532 Show fit | 42.44 |
ENSRNOT00000081952
|
RAB6B, member RAS oncogene family |
|
chr1_+_265298868 Show fit | 39.63 |
ENSRNOT00000023278
|
deleted in primary ciliary dyskinesia |
|
chr5_-_109651730 Show fit | 39.43 |
ENSRNOT00000093032
|
ELAV like RNA binding protein 2 |
|
chr1_-_89560719 Show fit | 37.82 |
ENSRNOT00000028653
|
sodium voltage-gated channel beta subunit 1 |
|
chr18_+_79406381 Show fit | 37.47 |
ENSRNOT00000022303
ENSRNOT00000058295 ENSRNOT00000058296 ENSRNOT00000022280 |
myelin basic protein |
|
chr13_+_92569785 Show fit | 36.72 |
ENSRNOT00000082700
|
formin 2 |
|
chr15_+_44799334 Show fit | 32.93 |
ENSRNOT00000018599
|
neurofilament light |
|
chr6_-_42473738 Show fit | 31.56 |
ENSRNOT00000033327
|
potassium voltage-gated channel modifier subfamily F member 1 |
|
chr11_+_72705129 Show fit | 30.13 |
ENSRNOT00000073330
|
apolipoprotein D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.1 | 85.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.5 | 61.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 60.7 | GO:0007612 | learning(GO:0007612) |
2.0 | 59.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.9 | 55.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
15.2 | 45.7 | GO:0021678 | third ventricle development(GO:0021678) |
14.8 | 44.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.1 | 43.7 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
3.0 | 42.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 40.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 125.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 121.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.2 | 97.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 83.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.9 | 79.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 69.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 64.0 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 59.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.7 | 53.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
2.8 | 50.5 | GO:0033268 | node of Ranvier(GO:0033268) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 106.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
17.1 | 85.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.9 | 71.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 69.1 | GO:0003779 | actin binding(GO:0003779) |
2.2 | 66.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
2.2 | 53.5 | GO:0005112 | Notch binding(GO:0005112) |
6.2 | 49.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
2.3 | 49.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.2 | 49.5 | GO:0031489 | myosin V binding(GO:0031489) |
3.8 | 46.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 92.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 63.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
4.2 | 29.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 27.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 26.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 23.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 20.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.4 | 18.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 16.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 14.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 149.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
7.2 | 135.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
3.6 | 61.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
3.8 | 56.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 47.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 38.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 34.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
1.5 | 32.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 31.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.7 | 30.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |